Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts

Vruyr Balian1, Michele Galli, Claudio Marcassa

  • 1Cardiologia Interventistica, Azienda Ospedaliera di Busto Arsizio, Varese, Italy. vbalian@aobusto.it

Circulation
|October 25, 2006
PubMed

Insights

Intracoronary ST-segment monitoring can quickly identify myocardial damage after percutaneous coronary intervention (PCI), even after successful procedures. This method aids in detecting patients who may need further treatment and extended hospital stays.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomarker Research

Background:

  • Elevated cardiac biomarkers post-percutaneous coronary intervention (PCI) indicate myocardial damage and predict adverse events.
  • Assessing periprocedural myocardial damage despite successful PCI is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the efficacy of intracoronary ST-segment recording using a guidewire for rapid identification of myocardial damage post-PCI.
  • To determine if intracoronary ST-segment shifts correlate with troponin I levels and predict adverse cardiac events.

Main Methods:

  • 108 patients undergoing elective single-vessel PCI had intracoronary ECG recorded via guidewire before and after the procedure.
  • Myocardial damage was defined by troponin I increase; intracoronary ST-segment shift > or = 1 mm was considered significant.
  • Long-term follow-up data on major coronary events were collected.

Main Results:

  • Myocardial damage occurred in 46% of patients, but only 10% had abnormal creatine kinase-MB.
  • Intracoronary ST-segment shift after PCI identified 93% of patients with myocardial damage, with 74% sensitivity and 95% specificity.
  • ST-segment shift was the sole independent predictor of myocardial damage (OR 54.1, P<0.0001).

Conclusions:

  • Intracoronary ST-segment shift effectively identifies myocardial injury post-PCI, even after successful interventions.
  • This technique offers a prompt, inexpensive method to detect patients requiring potential adjunctive therapy or longer hospitalization.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.2K
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522